Evidence map›Paper›PMID 31280589›Full record

ArticleCirculation2019

Microvascular Disease, Peripheral Artery Disease, and Amputation.

Joshua A Beckman, Meredith S Duncan, Scott M Damrauer, Quinn S Wells, Joey V Barnett, David H Wasserman, Roger J Bedimo, Adeel A Butt, Vincent C Marconi, Jason J Sico and 4 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Circulation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 105 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 6 pooled it
21.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05754814 completednot on this mapstarted 2022, after this paper: background citation

SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes

TypeobservationalSponsorRigshospitalet, DenmarkRan2022 to 2026Enrolled20ConditionsHead and Neck Cancer, Lymphoma, Lymph Node MetastasisArmsMalignant lymph nodes
NCT06319339 early_phase1recruitingnot on this mapstarted 2024, after this paper: background citation

Impact of Nrf2 Activation on Macrovascular Function, Microvascular Function, Leg Function, and Walking Capacity in Patients With Peripheral Artery Disease

TypeinterventionalSponsorUniversity of NebraskaRan2024 to 2026Enrolled20ConditionsPeripheral Artery Disease, Peripheral Vascular Diseases, Peripheral Arterial Disease, Peripheral Arterial Occlusive DiseaseArmsVumerity, Placebo
3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 6 syntheses or guidelines pooled it, 187 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Guideline
  5. Pooled it
  6. Guideline
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Microvascular dysfunction in chronic kidney disease: A feasibility study.Clinical physiology and functional imaging · 2026
    Article
  12. Article
  13. Observational
  14. Maximal Systolic Acceleration and Near-Infrared Fluorescence Imaging With Indocyanine Green as Predictors for Successful Lower Extremity Revascularization.Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists · 2026
    Article
  15. Observational
  16. Article
  17. Peripheral artery disease in diabetes.Frontiers in endocrinology · 2026
    Review
  18. Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 5 countries.

Joshua A BeckmanDivision of Cardiovascular Medicine (J.A.B., M.S.D., Q.S.W., A.W.A., M.S.F.), Nashville, TN.
Meredith S DuncanDivision of Cardiovascular Medicine (J.A.B., M.S.D., Q.S.W., A.W.A., M.S.F.), Nashville, TN.
Scott M DamrauerDepartment of Surgery, Perelman School of Medicine, University of Pennsylvania (S.M.D.), Philadelphia.
Quinn S WellsDivision of Cardiovascular Medicine (J.A.B., M.S.D., Q.S.W., A.W.A., M.S.F.), Nashville, TN.
Joey V BarnettDepartment of Pharmacology (J.V.B.), Nashville, TN.
David H WassermanVanderbilt University, Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine (D.H.W.), Nashville, TN.
Roger J BedimoInfectious Disease Section, VA North Texas Health Center and University of Texas Southwestern Medical Center, Dallas (R.J.B.).
Adeel A ButtDepartment of Medicine, Weill Cornell Medical College, New York, NY (A.A.B).
Vincent C MarconiAtlanta Veterans Affairs Medical Center and Emory University School of Medicine, GA (V.C.M.).
Jason J SicoVA Connecticut Healthcare System, West Haven (J.J.S.).
Hilary A TindleDivision of General Internal Medicine and Public Health (H.A.T.), Nashville, TN.
Marc P BonacaUniversity of Colorado School of Medicine and Colorado Prevention Center Clinical Research, Aurora (M.P.B.).
Aaron W AdayDivision of Cardiovascular Medicine (J.A.B., M.S.D., Q.S.W., A.W.A., M.S.F.), Nashville, TN.
Matthew S FreibergDivision of Cardiovascular Medicine (J.A.B., M.S.D., Q.S.W., A.W.A., M.S.F.), Nashville, TN.
Cardiovascular Research Center · BRBarnet Enfield and Haringey Mental Health Trust · GBCornell University · USEmory University · USFreiberger Compound Materials (Germany) · DEPhiladelphia VA Medical Center · USThe University of Texas Southwestern Medical Center · USUniversity of Colorado Denver · USVA Connecticut Healthcare System · USVanderbilt University · USVA Tennessee Valley Healthcare System · USWell Being Digital (China) · CN

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Alcohol and Multisubstance Use in the Veterans Aging Cohort StudyU01AA020790 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2011 to 2020
$7.7M
Training Program in the Epidemiology of CVDT32HL007575 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BURING, JULIE E., RIDKER, PAUL M. · 1985 to 2019
$5.0M
The Impact of Diabetes on Revascularization in BEST-CLIR01HL131977 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ADAY, AARON W., BECKMAN, JOSHUA A · 2016 to 2020
$4.0M
Immune function and the risk of cvd among HIV infected and uninfected veteransR01HL125032 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FREIBERG, MATTHEW S, TRACY, RUSSELL P · 2014 to 2017
$2.8M
Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk PredictionIK2CX001780 · VA · PHILADELPHIA VA MEDICAL CENTER · PI DAMRAUER, SCOTT MICHAEL · 2018 to 2023
–
CSRD VA IK2 CX001780NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL125032NHLBI NIH HHS R01 HL131977NHLBI NIH HHS T32 HL007575NIAAA NIH HHS U01 AA020790
6 · The paper itself

Abstract

backgroundThe mechanism of adverse limb events associated with peripheral artery disease remains incompletely understood. We investigated whether microvascular disease is associated with amputation in a large cohort of veterans to determine whether microvascular disease diagnosed in any location increases the risk of amputation alone and in concert with peripheral artery disease.

methodsParticipants in the Veterans Aging Cohort Study were recruited from April 1, 2003 through December 31, 2014. We excluded participants with known prior lower limb amputation. Using time-updated Cox proportional hazards regression, we analyzed the effect of prevalent microvascular disease (retinopathy, neuropathy, and nephropathy) and peripheral artery disease status on the risk of incident amputation events after adjusting for demographics and cardiovascular risk factors.

resultsAmong 125 674 veterans without evidence of prior amputation at baseline, the rate of incident amputation over a median of 9.3 years of follow-up was 1.16 per 1000 person-years, yielding a total of 1185 amputations. In time-updated multivariable-adjusted analyses, compared with those without peripheral artery disease or microvascular disease, microvascular disease alone was associated with a 3.7-fold (95% CI, 3.0-4.6) increased risk of amputation; peripheral artery disease alone conferred a 13.9-fold (95% CI, 11.3-17.1) elevated risk of amputation; and the combination of peripheral artery disease and microvascular disease was associated with a 22.7-fold (95% CI, 18.3-28.1) increased risk of amputation.

conclusionsIndependent of traditional risk factors, the presence of microvascular disease increases the risk of amputation alone and synergistically increases risk in patients with peripheral artery disease. Further research is needed to understand the mechanisms by which this occurs.

Indexed as

Amputation, SurgicalMicrocirculationAdultAgedComorbidityDiabetes ComplicationsDisease SusceptibilityExtremitiesFemaleFollow-Up StudiesHumansIschemiaKidney DiseasesMaleMiddle AgedPeripheral Arterial Diseaseamputationcardiovascular diseasesperipheral artery diseaserisk factorsveterans

Identifiers

PMID31280589
PMCPMC6682431
OpenAlexW2961925837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.